A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
Recruiting · NCT07227831 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-08-26 | NCT07227831 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Barbara Ann Karmanos Cancer Institute | 29 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Karmanos Cancer Institute | Detroit | United States | 153 |
| Karmanos Cancer Institute at McLaren Bay Region | Bay City | United States | 5 |
| Karmanos Cancer Institute at McLaren Clarkston | Clarkston | United States | 6 |
| Karmanos Cancer Institute at McLaren Flint | Flint | United States | 7 |
| Karmanos Cancer Institute at McLaren Lapeer Region | Lapeer | United States | 4 |
| Karmanos Cancer Institute at McLaren Macomb | Mount Clemens | United States | 2 |
| Karmanos Cancer Institute at McLaren Northern | Petoskey | United States | 1 |
| Karmanos Cancer Institute at McLaren Port Huron | Port Huron | United States | 6 |